Corcept Therapeutics, Inc. (CORT)
34.82
+0.58
(+1.69%)
USD |
NASDAQ |
Feb 20, 16:00
34.60
-0.22
(-0.63%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 3.663B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Axsome Therapeutics, Inc. | 9.262B |
| United Therapeutics Corp. | 20.38B |
| Harrow, Inc. | 1.926B |
| Ultragenyx Pharmaceutical, Inc. | 2.192B |
| Amneal Pharmaceuticals, Inc. | 4.558B |
Market Cap Related Metrics
| PE Ratio | 39.79 |
| PS Ratio | 5.616 |
| Price to Book Value | 5.796 |
| Price to Free Cash Flow | 25.61 |
| Price | 34.82 |
| Earnings Yield | 2.51% |
| Operating PE Ratio | 63.48 |
| Normalized PE Ratio | 39.79 |